Roberto Benini

1.7k total citations
8 papers, 1.2k citations indexed

About

Roberto Benini is a scholar working on Cardiology and Cardiovascular Medicine, Nephrology and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Roberto Benini has authored 8 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Cardiology and Cardiovascular Medicine, 6 papers in Nephrology and 2 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Roberto Benini's work include Renin-Angiotensin System Studies (5 papers), Renal Diseases and Glomerulopathies (5 papers) and Blood Pressure and Hypertension Studies (4 papers). Roberto Benini is often cited by papers focused on Renin-Angiotensin System Studies (5 papers), Renal Diseases and Glomerulopathies (5 papers) and Blood Pressure and Hypertension Studies (4 papers). Roberto Benini collaborates with scholars based in Italy and United Kingdom. Roberto Benini's co-authors include Giuseppe Remuzzi, Annalisa Perna, Piero Ruggenenti, Giulia Gherardi, Flavio Gaspari, Carmine Zoccali, Piero Ruggenenti, Dominic Yu, Tim Meyer and Philip J. Johnson and has published in prestigious journals such as The Lancet, Kidney International and Journal of the American Society of Nephrology.

In The Last Decade

Roberto Benini

8 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Roberto Benini Italy 8 587 579 285 243 176 8 1.2k
G Garini Italy 13 786 1.3× 696 1.2× 306 1.1× 103 0.4× 588 3.3× 32 1.8k
Francesco Locatelli Italy 4 143 0.2× 434 0.7× 228 0.8× 97 0.4× 53 0.3× 5 844
Kerry Willis United States 7 207 0.4× 477 0.8× 240 0.8× 42 0.2× 122 0.7× 13 874
Ulrich Neyer Austria 21 246 0.4× 1.2k 2.0× 259 0.9× 117 0.5× 182 1.0× 32 2.1k
Lars Weiss Sweden 17 163 0.3× 633 1.1× 256 0.9× 64 0.3× 89 0.5× 28 1.0k
Wolfgang Ramlow Germany 17 167 0.3× 167 0.3× 139 0.5× 196 0.8× 117 0.7× 51 1.2k
Yunhua Liao China 15 113 0.2× 324 0.6× 131 0.5× 88 0.4× 93 0.5× 35 835
Sören Madsen Denmark 12 139 0.2× 329 0.6× 200 0.7× 102 0.4× 179 1.0× 17 1.4k
Marcia Landa United States 7 660 1.1× 781 1.3× 245 0.9× 14 0.1× 205 1.2× 7 1.4k
S Oren Israel 11 747 1.3× 292 0.5× 458 1.6× 16 0.1× 118 0.7× 28 1.2k

Countries citing papers authored by Roberto Benini

Since Specialization
Citations

This map shows the geographic impact of Roberto Benini's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Roberto Benini with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Roberto Benini more than expected).

Fields of papers citing papers by Roberto Benini

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Roberto Benini. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Roberto Benini. The network helps show where Roberto Benini may publish in the future.

Co-authorship network of co-authors of Roberto Benini

This figure shows the co-authorship network connecting the top 25 collaborators of Roberto Benini. A scholar is included among the top collaborators of Roberto Benini based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Roberto Benini. Roberto Benini is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
1.
Kadalayil, Latha, Roberto Benini, Lalit Pallan, et al.. (2013). A simple prognostic scoring system for patients receiving transarterial embolisation for hepatocellular cancer. Annals of Oncology. 24(10). 2565–2570. 249 indexed citations
2.
Ruggenenti, Piero, et al.. (2001). Ramipril prolongs life and is cost effective in chronic proteinuric nephropathies. Kidney International. 59(1). 286–294. 39 indexed citations
3.
Ruggenenti, Piero, Annalisa Perna, Giulia Gherardi, Roberto Benini, & Giuseppe Remuzzi. (2000). Chronic proteinuric nephropathies: Outcomes and response to treatment in a prospective cohort of 352 patients with different patterns of renal injury. American Journal of Kidney Diseases. 35(6). 1155–1165. 127 indexed citations
4.
Perna, Annalisa, Piero Ruggenenti, A. Testa, et al.. (2000). ACE genotype and ACE inhibitors induced renoprotection in chronic proteinuric nephropathies1. Kidney International. 57(1). 274–281. 67 indexed citations
5.
Ruggenenti, Piero, Annalisa Perna, Carmine Zoccali, et al.. (2000). Chronic Proteinuric Nephropathies. II. Outcomes and Response to Treatment in a Prospective Cohort of 352 Patients. Journal of the American Society of Nephrology. 11(1). 88–96. 88 indexed citations
6.
Ruggenenti, Piero, Annalisa Perna, Roberto Benini, et al.. (1999). In Chronic Nephropathies Prolonged ACE Inhibition Can Induce Remission. Journal of the American Society of Nephrology. 10(5). 997–1006. 143 indexed citations
7.
Ruggenenti, Piero, Annalisa Perna, Giulia Gherardi, et al.. (1998). Renal function and requirement for dialysis in chronic nephropathy patients on long-term ramipril: REIN follow-up trial. The Lancet. 352(9136). 1252–1256. 413 indexed citations
8.
Ruggenenti, Piero, Annalisa Perna, Roberto Benini, & Giuseppe Remuzzi. (1998). Effects of dihydropyridine calcium channel blockers, angiotensin-converting enzyme inhibition, and blood pressure control on chronic, nondiabetic nephropathies. Gruppo Italiano di Studi Epidemiologici in Nefrologia (GISEN).. Journal of the American Society of Nephrology. 9(11). 2096–2101. 102 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026